Spots Global Cancer Trial Database for Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer
Official Title: Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer
Study ID: NCT02830282
Conditions
Interventions
Study Description
Brief Summary: This is a nested multicenter, prospective cohort study within the I-SPY 2 TRIAL for women undergoing neoadjuvant chemotherapy for primary breast cancer who are also undergoing definitive surgical resection and have clinical or radiographic evidence of residual tumor at the completion of chemotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact Details
Name: Angela DeMichele, MD
Affiliation: Abramson Cancer Center at Penn Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
